Jean-Baptiste Trouiller

4PUBLICATIONS
4CO-AUTHORS
Economic models and forecastingSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 02, 2025
The Acceptance of Overall Survival Extrapolation Methods in Solid Tumor Treatments by Health Technology Assessment Agencies in England, France, and Australia between 2017 and 2022.

Jean-Baptiste Trouiller, Arthur Quenéchdu, Mondher Toumi

|Jul 22, 2023
Comparative Assessment of Reimbursement Recommendations by NICE and HAS for Oncology New Medicines Indicated for the Treatment of Solid Tumors from 2015 to 2021.

Jean-Baptiste Trouiller, Philippe Laramée

|Jul 11, 2023
Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma.

Jean-Baptiste Trouiller, Georgios F Nikolaidis, Bérengère Macabeo

|Nov 21, 2022
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial.

Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll

Pageof 1

Frequent Collaborators

2 joint publications

Philippe Laramée

1 joint publications

David Malka

1 joint publications

Georgios F Nikolaidis

1 joint publications

Max Schlueter